Literature DB >> 22160507

Single-session combined photodynamic therapy with verteporfin and intravitreal anti-vascular endothelial growth factor therapy for chronic central serous chorioretinopathy: a pilot study at 12-month follow-up.

Shiu Ting Mak, Albert Chak-ming Wong.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22160507     DOI： 10.1007/s00417-011-1883-6

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN： 0721-832X            Impact factor:   3.117


× No keyword cloud information.
  10 in total

1.  Ocular changes after photodynamic therapy.

Authors:  Radouil Tzekov; Ton Lin; Kai-Ming Zhang; Brittany Jackson; Adelekan Oyejide; Werhner Orilla; Amol D Kulkarni; Baruch D Kuppermann; Larry Wheeler; James Burke
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-01       Impact factor: 4.799

2.  Choroidal neovascularization complicating photodynamic therapy for central serous retinopathy.

Authors:  Michael Colucciello
Journal:  Retina       Date:  2006-02       Impact factor: 4.256

3.  Single-session combined photodynamic therapy with verteporfin and intravitreal anti-vascular endothelial growth factor therapy for chronic central serous chorioretinopathy: a pilot study at 12-month follow-up.

Authors:  J Fernando Arevalo; Juan V Espinoza
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-03-30       Impact factor: 3.117

4.  Polypoidal choroidal vasculopathy masquerading as central serous chorioretinopathy.

Authors:  L A Yannuzzi; K B Freund; M Goldbaum; B Scassellati-Sforzolini; D R Guyer; R F Spaide; D Maberley; D W Wong; J S Slakter; J A Sorenson; Y L Fisher; D A Orlock
Journal:  Ophthalmology       Date:  2000-04       Impact factor: 12.079

5.  Choroidal vascular remodelling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease level.

Authors:  W-M Chan; D S C Lam; T Y Y Lai; B S M Tam; D T L Liu; C K M Chan
Journal:  Br J Ophthalmol       Date:  2003-12       Impact factor: 4.638

6.  Polypoidal choroidal vasculopathy: an angiographic discussion.

Authors:  T H Lim; A Laude; C S H Tan
Journal:  Eye (Lond)       Date:  2010-01-15       Impact factor: 3.775

7.  Half-dose verteporfin photodynamic therapy for acute central serous chorioretinopathy: one-year results of a randomized controlled trial.

Authors:  Wai-Man Chan; Timothy Y Y Lai; Ricky Y K Lai; David T L Liu; Dennis S C Lam
Journal:  Ophthalmology       Date:  2008-06-05       Impact factor: 12.079

8.  Transient reduction in retinal function revealed by multifocal electroretinogram after photodynamic therapy.

Authors:  Timothy Y Y Lai; Wai-Man Chan; Dennis S C Lam
Journal:  Am J Ophthalmol       Date:  2004-05       Impact factor: 5.258

9.  Safety enhanced photodynamic therapy for chronic central serous chorioretinopathy: one-year results of a prospective study.

Authors:  Wai-Man Chan; Timothy Y Y Lai; Ricky Y K Lai; Emily W H Tang; David T L Liu; Dennis S C Lam
Journal:  Retina       Date:  2008-01       Impact factor: 4.256

10.  Declaration of Helsinki, 2008: implications for stakeholders in research.

Authors:  K S Puri; K R Suresh; N J Gogtay; U M Thatte
Journal:  J Postgrad Med       Date:  2009 Apr-Jun       Impact factor: 1.476
  10 in total
  1 in total

1.  Alternating central serous chorioretinopathy in two consecutive pregnancies.

Authors:  Abdullah Al-Mujaini; Upender Wali
Journal:  Oman J Ophthalmol       Date:  2014-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.